News

Featured News

  • 2019 |
  • 2018 |
  • 2017 |
  • News | December 18, 2018

    Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita

    Read More

    Press Release | December 18, 2018

    Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform

    Read More

    Press Release | December 13, 2018

    Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

    Read More

    Press Release | December 6, 2018

    Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space

    Read More